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Background: Connexin 43 (Cx43) is the predominant gap junction protein in bone. Mice with a bone-specific
deletion of Cx43 (cKO) have an osteopenic cortical phenotype. In a recent study, we demonstrated that cKO mice
are resistant to bone loss induced by hindlimb suspension (HLS), an animal model of skeletal unloading. This
protective effect occurred primarily as a result of lower osteoclast-mediated bone resorption. Interestingly, we also
documented a significant increase in cortical osteocyte apoptosis and reduced sclerostin production. In the present
study, we investigated whether osteocytic osteolysis – bone resorption by osteocytes within lacunae – is induced
by HLS and the potential effect of Cx43 deficiency on this process during unloading.
Methods: 6-month-old male Cx43 cKO or wild-type (WT) mice were subjected to three weeks of HLS (Suspended)
or normal loading conditions (Control) (n = 5/group). Lacunar morphology and tartrate-resistant acid phosphatase
(TRACP) staining were assessed on sections of femur cortical bone. Experimental groups were compared via two-
way ANOVA.
Results: Empty lacunae were 26% larger in cKO-Control vs. WT-Control (p < 0.05), while there was no difference in
the size of empty lacunae between Control and Suspended within WT or cKO (p > 0.05). Similarly, there was a trend
(p = 0.06) for 11% larger lacunae containing viable osteocytes for cKO-Control vs. WT-Control, with no apparent
effect of loading condition. There was no difference in the proportion of TRACP + cells between WT-Control and
cKO-Control (p > 0.05); however, WT-Suspended mice had 246% more TRACP + osteocytes compared WT-Control
mice (p < 0.05). There was no difference in TRACP staining between cKO-Control and cKO-Suspended (p > 0.05).
Conclusions: Prior to undergoing apoptosis, osteocytes in cKO mice may be actively resorbing their respective
lacunae via the process of osteocytic osteolysis. Interestingly, the proportion of TRACP + osteocytes increased
dramatically following unloading of WT mice, an effect that was not observed in cKO mice subjected to HLS. The
results of the present study provide initial evidence that osteocytic osteolysis is occurring in cortical bone in
response to mechanical unloading. Furthermore, Cx43 deficiency appears to protect against osteocytic osteolysis in
a manner similar to the inhibition of unloading-induced osteoclast activation that we have documented previously.
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Intercellular communication via gap junctions is one of
the critical mediators of the skeletal response to mech-
anical force. Gap junctions are protein channels that
allow for the direct movement of small molecules be-
tween adjacent cells [1] or between the cell and extra-
cellular environment [2,3]. Gap junction proteins also
interact with scaffold proteins and intercellular signaling
molecules, such as β-catenin [3-6]. Connexin 43 (Cx43)
is the predominant gap junction protein in bone [7] and
has been shown to have an important role in the ana-
bolic response to mechanical loading both in vitro and
in vivo [5,8,9]. However, the role of Cx43 in the catabolic
response to mechanical unloading (i.e., disuse, lack of
weight bearing) is not as well defined.
Mechanical unloading results in significant deleterious
effects on the musculoskeletal system. For example, as-
tronauts on four to six month missions aboard the Inter-
national Space Station lose bone at a rate of 1-2% per
month in load bearing bones [10], with incomplete re-
covery one year after returning to Earth [11]. Unloading-
induced bone loss is characterized by an increase in
osteoclast-mediated bone resorption (primarily mediated
via receptor activator of nuclear factor kappa-B ligand;
RANKL [12]) with a decrease in osteoblast-mediated bone
formation (primarily mediated by osteocyte-derived scler-
ostin, an inhibitor of Wnt/β-catenin signaling [13,14]).
Unloading-induced bone loss is also associated with pro-
longed bed rest [15,16], neurological injury or trauma
[17], and reduced physical activity in the elderly [18]. Re-
gardless of the specific cause, unloading-induced bone loss
may increase fracture risk and increase individual morbid-
ity and mortality [19,20].
Previous studies from our laboratory have subjected
mice with an osteoblast/osteocyte-selective deficiency of
Cx43 (cKO) to mechanical unloading using the hindlimb
suspension (HLS) model [21,22]. HLS has been well-
validated as the standard for ground-based simulation of
the effects of microgravity and bed rest, including a lack
of weight bearing in the hind quarters, cephalic fluid shift,
and maintenance of passive muscle activity [23]. Following
three weeks of HLS, we were able to detect significant at-
tenuation of trabecular bone loss in cKO mice [21]. In
addition, bone formation rate at the femur midshaft of
unloaded cKO mice was maintained at baseline levels, as
opposed to the characteristic suppression of bone forma-
tion observed in unloaded wild-type (WT) mice. In a sub-
sequent study, we found that Cx43 cKO mice subjected to
HLS experienced attenuated endocortical osteoclast activ-
ity [22]. Similarly, Grimston and colleagues found attenu-
ated bone resorption in Cx43 deficient mice subjected to
hindlimb immobilization via botulinum toxin [24].
In addition to osteoclast-mediated bone resorption,
recent studies have suggested an important role forosteocytes in bone turnover and skeletal homeostasis via
the process of osteocytic osteolysis – direct resorption of
bone by osteocytes within their respective lacunae
[25-27]. Osteocytes are well positioned for this function
given that they are the most abundant cell type in bone
and, as opposed to osteoclasts and osteoblasts, they are
exposed to a much larger surface area of bone via the
lacunar-canalicular network [28].
The baseline cortical phenotype of Cx43 deficient mice
is osteopenic, with cortical thinning and marrow expan-
sion due to increased endocortical osteoclast activity
[9,24]. We have also documented significantly increased
cortical porosity in cKO mice [21]. While not a definitive
report, the present study represents an initial investiga-
tion of the role of Cx43 in the process of intracortical re-
sorption via osteocytic osteolysis. We subjected WT and
Cx43 cKO mice to three weeks of HLS. We found an in-
creased number of empty and enlarged lacunae through-
out the cortical bone of cKO mice at baseline, and
increased tartrate-resistant acid phosphatase (TRACP)-
positive osteocytes in WT mice following HLS. Taken
together, these findings suggest a potential role of osteo-
cytic osteolysis in the cortical osteopenic phenotype of




Given that global knockout of the Cx43 gene is embryonic
lethal [29], we utilized mice with conditional deletion of
the gene encoding Connexin 43 (Gja1) specifically in oste-
oblasts and osteocytes. Our strategy for generation of
transgenic mice, confirmation of conditional knockout,
and determination of the specificity of the Cx43 deletion
was described previously [9,21,22]. Briefly, mice express-
ing Cre recombinase under the control of the human
osteocalcin promoter (OC-Cre; Cx43+/+) [30] were bred
with mice in which Gja1 is flanked by two loxP sites
(Cx43flx/flx) [31] to generate OC-Cre; Cx43flx/+ mice. We
then crossed OC-Cre; Cx43flx/+ mice with Cx43flx/flx mice
to generate OC-Cre; Cx43flx/flx mice. We then back bred
OC-Cre; Cx43flx/flx mice with Cx43flx/flx mice to generate
an equal number of OC-Cre; Cx43flx/flx (conditional Cx43
deficient equivalent; cKO) and Cx43flx/flx (wild-type; WT).
Mice derived from this breeding strategy were bred with
C57BL/6 mice for three generations. Genotyping was per-
formed using DNA isolated from mouse earpieces and ap-
propriate primers [9]. The mice used to generate the data
presented in this manuscript were the same mice used in
a previous study [22].
Animal procedures
We utilized six-month-old male Cx43 cKO and WT
mice. Mice of this age and sex were selected due to their
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studies of mechanical loading [9] and unloading [21,22].
Mice were housed in the central animal facility at the
Penn State College of Medicine (Hershey, PA, USA).
Mice were fed standard 2018 Teklad Global 18% Protein
Rodent Diet (Harlan Laboratories, Inc.; Indianapolis, IN,
USA), maintained at a constant temperature of 25°C,
and kept on a 12 hour light/dark cycle during all experi-
mental procedures. Mice were housed in standard vivar-
ium enclosures until one-week prior to experimentation,
when they were moved to the hindlimb suspension (HLS)
enclosures (2 mice per cage) in order to acclimatize under
normal loading conditions. WT and cKO mice were then
placed into normally loaded (i.e., Control) and HLS (i.e.,
Suspended) groups (n = 5/group).
The HLS method utilized was a modified version of
that first described by Morey-Holton and colleagues [32]
and utilized previously by our laboratory [21,22]. The
HLS enclosures consisted of a standard rat enclosure
with several modifications. The bottom of the cage con-
tained a wire mesh insert with standard bedding placed
below. Two metal crossbars were located at either end
of the cage, along with water bottles. Under isoflurane
anesthesia (2%), two thin strips of bandage tape were
then braided around the tail and secured with additional
tape at the base of the tail and end. The loose ends of
the tape were then fixed to a swivel hook attached to a
string. The string was wound around the cross bar at
the top of the cage. In this manner, the crossbar could
be rotated, thus raising or lowering the hindquarters of
the animal to achieve a 30° elevation. This angle of sus-
pension has been previously demonstrated to keep the
forelimbs normally-loaded, while minimizing tail tension
and animal stress [33]. Two mice were suspended per
cage in this manner, although their placement at oppos-
ite ends prevented physical contact. Based on our previ-
ous experiments, the experimental period of unloading
was three weeks [21]. Control mice were housed in this
same cage environment, albeit without attachment of
the HLS apparatus. The health and activity of the ani-
mals was assessed daily by laboratory and veterinary
staff. All animal procedures were approved by the Insti-
tutional Animal Care and Use Committee at the Penn
State College of Medicine (Protocol 2010–117).
Histology and TRACP staining
Left femurs were harvested immediately after sacrifice
and cleaned of all non-osseous tissue. Femurs were then
fixed in 10% neutral buffered formalin for 3 days. All fe-
murs were subjected to 7 days of decalcification in ster-
ile 14% ethylenediaminetetraacetic acid at pH 7.4.
Femurs were then processed and embedded in paraffin.
5 μm sections (n = 5/group) were used for all analyses.
The femur was sectioned longitudinally. We analyzed a2400 μm lateral section of the cortical bone centered
about the midshaft of the femur. We analyzed the entire
thickness of cortical bone, from the periosteal to endo-
cortical surface.
Sections were stained with Alcian blue/hematoxylin/
Orange G/Eosin (i.e., H&E) or used for TRACP staining.
For TRACP staining, following de-waxing and rehydra-
tion, slides were incubated in 0.2 M Acetate Buffer
(0.2 M Sodium Acetate, 50 mM L(+) tartaric acid;
pH 5.0) (Sigma Aldrich; St. Louis, MO, USA) for 20 mi-
nutes at room temperature. 0.5 mg/mL Napthol AS-MX
phosphate (Sigma) and 1.1 mg/mL Fast Red TR salt
(Sigma) were then added to the 0.2 M Acetate Buffer
and sections were incubated at 37°C for 2 hours. Sec-
tions were then rinsed in distilled water, counterstained
in 0.5% Methyl Green (in 100 mM Acetate Buffer;
pH 4.2) for 1 minute, washed in running tap water for
5 minutes, dipped in 50% ethanol (Sigma) five times, air
dried, and mounted with aqueous Fluoromount-G
(Southern Biotech; Birmingham, AL, USA).
All images were acquired using a Nikon Optiphot-2
microscope (Nikon Instruments Inc.; Melville, NY, USA)
with 20× objective. Approximately 50–75 images were
used to capture the femur diaphysis. These smaller im-
ages were stitched together in to one large panorama
using Microsoft Image Composite Editor (Microsoft
Corporation; Redmond, WA, USA).
H&E-stained sections were used to identify viable osteo-
cytes or empty lacunae. All lacunae in this region were
manually traced in order to determine the length of their
perimeter (mm) or circularity. Circularity is an index of
roundness and is calculated as 4π[(Area)/(Perimeter2)]. It
can range from 0 (an infinitely elongated polygon) to 1 (a
perfect circle). In TRACP-stained sections, the number of
TRACP + osteocytes was counted in a 2400 μm length
(longitudinal) of cortical bone at the femur midshaft. Mea-
surements were made on n = 5/group. BioQuant Osteo
software (v12.5.60, BIOQUANT Image Analysis Corpor-
ation; Nashville, TN, USA) was used for all image analysis.
Immunohistochemistry
Paraffin sections were de-waxed, dehydrated, and under-
went antigen retrieval using sodium citrate buffer (pH 6.0).
Sections were probed with anti-Cx43 (#SAB4300504,
Sigma) antibody diluted 1:500 in normal goat serum,
followed by goat anti-rabbit secondary antibody (#PK6101,
Vector Laboratories; Burlingame, CA), and staining was
visualized with DAB chromogen (Invitrogen). Sections
were counterstained with methyl green. 20× images of
cortical bone at the femur midshaft were taken.
Statistical analyses
Statistical analysis was conducted using GraphPad Prism
(v5.0f, GraphPad Software Inc.; La Jolla, CA, USA). Data
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ation of the data was performed using a two-way
ANOVA with post-hoc Student-Newman-Keuls test
when the interaction was significant (p < 0.05).
Results
Body weight
Consistent with our previous studies [9,21], baseline
body weight of mice was not different between WT
(31.3±0.8 g) and cKO (31.2±0.9 g) (p > 0.05). Body
weight of control mice did not change from day 0 at any
time point during the study. Mice subjected to HLS lost
a similar amount of body weight, ending the experiment
at a similar −5% and −3% of day 0 for WT-Suspended
and cKO-Suspended, respectively (p < 0.05). The degree
of weight loss during HLS is similar to our previous
studies [21,22] and not unexpected following HLS of
mature rodents [32].
Confirmation of connexin 43 deficient phenotype
Using appropriate primers [9], we identified mice as ei-
ther cKO via positive expression of osteocalcin-driven
cre recombinase (OC-Cre) or WT equivalent via nega-
tive expression of OC-Cre. Expression of “floxed” Gja1
was used as a positive control.
As expected, there were relatively few Cx43+ osteo-
cytes in the cortical bone of cKO mice compared to WT
(Figure 1; left panels). Numerous empty lacunae were
noted throughout the cortical bone of cKO mice. TheseFigure 1 Cx43 expressing osteocytes. Left: Representative images
demonstrate the relative absence of Cx43+ osteocytes in the femur
midshaft cortical bone of cKO mice compared to WT. Red arrow:
Cx43+ osteocyte, blue arrow: Cx43- osteocyte, white arrow: empty
lacunae. The black bar represents 25 μm. Right: Cross-sections of the
femur midshaft taken via light microscope reveal the osteopenic
cortical phenotype of cKO mice. The black bar represents 1000 μm.subjective findings are consistent with our previous
study, which documented 63% empty lacunae in cKO
mice, compared to 9% empty lacunae in WT [22]. A
light micrograph cross-section of cortical bone at the
femur midshaft highlights the distinctive osteopenic
phenotype of cKO mice (Figure 1; right panels), with ex-
panded marrow area and cortical thinning. Specific
quantification of the cortical phenotype of Cx43 defi-
ciency has been documented previously by our group
[9,21] and others [24,34] using high-resolution micro-
computed tomography.
Cortical lacunae are larger in connexin 43 deficient mice
We found no significant difference between any of the
groups with respect to absolute number of lacunae or la-
cunar density (p > 0.05; Table 1).
There was a non-significant trend (p = 0.06) indicating
that the size of lacunae containing viable osteocytes was
greater in cKO-Control mice relative to WT-Control
(+11%) (Figure 2A). As osteocytes resorb the surround-
ing cortical bone, the shape of their respective lacunae
might be expected to become irregular or elongated
[35]. However, we were not able to detect a decrease in
the relative circularity of lacunae containing viable oste-
ocytes (Figure 2B). Empty lacunae in cKO-Control mice
were 26% larger than those in WT-Control (p < 0.05;
Figure 2C), although there were no differences between
Suspended and Control within a genotype (p > 0.05).
There was no difference in the circularity of empty lacu-
nae (Figure 2D).
TRACP + osteocytes are increased in number during
mechanical unloading
TRACP + osteocytes are an indicator of osteocytic oste-
olysis [25,36]. TRACP-stained sections of femur cortical
bone were used to quantify the number of TRACP + os-
teocytes, with representative images shown in Figure 3A.
There was no difference in the percentage of TRACP + os-
teocytes quantified relative to total lacunae between WT-
and cKO-Control (p > 0.05; Figure 3B). However, we did
observe there to be 246% more TRACP + osteocytes in
WT-Suspended mice relative to WT-Control (p < 0.05).Table 1 Quantification of lacunar number and density in
cortical bone





WT-Control 261 ± 13 0.27 ± 0.01 980 ± 45
WT-Suspended 226 ± 13 0.22 ± 0.02 1054 ± 76
cKO-Control 240 ± 24 0.27 ± 0.04 937 ± 91
cKO-Suspended 253 ± 33 0.23 ± 0.02 1105 ± 64
Lacunae were quantified within a 2400 μm linear region of the mid-diaphysis
of the femur. There were no significant differences (p > 0.05) between any of
the groups. Comparisons via two-way ANOVA. Mean ± SE.
Figure 2 Osteocyte size and circularity. Quantification of the relative size and circularity of (A, B) lacunae containing viable osteocytes and (C, D)
empty lacunae in cortical bone from wild-type (WT) and Cx43 conditional knockout (cKO) mice following three weeks of normal loading conditions
(Control) or mechanical unloading via hindlimb suspension (Suspended). Lacunae were quantified within a 2400 μm linear region of the mid-diaphysis
of the femur. Mean ± SE. * indicates a significant difference (p < 0.05) between Control and Suspended within a genotype, while † indicates a
significant difference (p < 0.05) between WT and cKO within a loading condition. n = 5/group.
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osteocytes between cKO-Control and cKO-Suspended
(p > 0.05).
Discussion
Evidence for the process of osteocytic osteolysis comes
from studies demonstrating that osteocytes can stain
positive for TRACP, an enzyme typically associated with
osteoclasts that is critical to their bone resorptive activity
[36]. Increased TRACP gene expression has also been
demonstrated in osteocyte-enriched bone fractions [25].
In the present study, we found that unloaded WT mice
had nearly 2.5 times more TRACP + osteocytes than nor-
mally loaded WT mice at the femur midshaft. These
findings indicate a potential increase in osteocyte resorp-
tive activity during unloading. Similarly, Blaber and col-
leagues demonstrated that mice flown for fifteen days on
the space shuttle had a greater proportion of TRACP +
osteocytes when compared to ground controls [35]. Con-
versely, Qing colleagues found no increase in TRACP +
osteocytes in female CD1 subjected to HLS [25]. It isimportant to note, however, that the strain (CD1 vs. black
6 background), sex (female vs. male), age (3 months vs.
4 months), duration of unloading (4 weeks vs. 3 weeks),
and ground control (attached tail device vs. free ambula-
tion) make a direct comparison to the present study diffi-
cult. Regardless, it is clear that additional work is required
to reconcile findings in both ground-based controls and in
comparison to spaceflight unloading.
Despite an increase in TRACP staining, we were not
able to resolve any difference in the relative size or shape
of the lacunae in unloaded mice. Qing and colleagues
also found no difference between normal control and
HLS mice with respect to the size of cortical lacunae
[25]. However, it is important to note that HLS is not
able to recapitulate all of the effects of true skeletal
unloading, a state more closely approximated in micro-
gravity. HLS may result in a relatively lower magnitude
of lacunar remodeling that is harder to detect. Indeed,
spaceflight studies involving both rats [37] and mice
[35,38] have reported the appearance of lacunar enlarge-
ment, including increased area, perimeter, and reduced
Figure 3 TRAP expressing osteocytes. (A) A representative TRACP-stained section of the femur midshaft cortical bone demonstrates the
greater number of TRACP + osteocytes in WT-Suspended mice compared to Control, with no difference seen in cKO-Suspended. (B) TRACP +
osteocytes were quantified relative to total number of lacunae. The black bar represents 25 μm. Red arrow: TRACP + osteocyte, blue arrow:
TRACP- osteocyte, white arrow: empty lacunae. Comparisons via two-way ANOVA. Mean ± SE. * indicates a significant difference (p < 0.05)
between Control and Suspended within a genotype, while † indicates a significant difference (p < 0.05) between WT and cKO within a loading
condition. n = 5/group.
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diameter. Interestingly, lactating mice have also been
shown to have increased lacunar size [25,26].
As opposed to WT mice, there was no increase in
TRACP + osteocytes in cKO mice subjected to unload-
ing. Previous studies from our laboratory [22] and an-
other [24] have documented lower cortical osteoclast
activity in unloaded cKO mice compared to unloaded
WT. Cx43 deficiency appears to effectively desensitize
cortical bone to the unloaded state. The results of the
present study suggest that Cx43 deficiency has a similar
effect on the threshold for initiation of osteocyte resorp-
tive activity during unloading. Osteocytes are the pri-
mary source of sclerostin and receptor activator of
nuclear factor kappa-β ligand (RANKL) during unload-
ing, resulting in suppression of bone formation and acti-
vation of bone resorption, respectively. Lower osteocyte
viability induced by Cx43 deficiency [22,34] may partially
explain the protective effects of Cx43 deficiency during
mechanical unloading. However, prior to undergoing
apoptosis, osteocytes may be actively resorbing their re-
spective lacunae, thus contributing to the baseline osteo-
penic phenotype of Cx43 deficiency. We documented a
trend towards increased size of lacunae containing viable
osteocytes in cKO-Control mice compared to WT-
Control. Furthermore, the size of empty lacunae, which
presumably contained an actively resorbing osteocyte for
a longer period of time prior to cell death, were a signifi-
cant 26% larger. The accumulation of larger, emptylacunae may account for the 156% greater cortical por-
osity we documented in cKO mice versus WT [21].
We were not able to detect a difference in the propor-
tion of TRACP + osteocytes between cKO- and WT-
Control; however, it is important to note that TRACP +
osteocytes were quantified relative to the total number
of lacunae. Given the large proportion of empty lacunae
in cKO-Control mice, it is likely that the proportion of
TRACP + cells relative to viable cells was actually in-
creased for cKO-Control vs. WT-Control. In addition, it
is likely that any TRACP + osteocytes that were actively
resorbing and enlarging their lacunae have since died,
leaving unstained, empty lacunae behind. Unfortunately,
we were not able to quantify TRACP + cells relative to
viable osteocytes, as we could not accurately differentiate
TRACP- osteocytes from empty lacunae in our histo-
logical sections. An important limitation of the present
study involves our ability to accurately identify the cells
that are occupying the cortical lacunae. A previous study
from our laboratory, utilizing tissue sections from these
same animals, identified the cells as staining positive for
sclerostin [22]. Combined with their location embedded
within the bone matrix, it is likely that the cells in ques-
tion are indeed osteocytes. However, future studies
should investigate staining for other osteocyte markers,
including sclerostin (Sost) and dentin matrix acidic
phosphoprotein 1 (Dmp-1), to confirm absolutely their
identity. It would also be interesting to investigate the
formation of actin rings in TRACP-positive osteocytes,
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resorptive pit by osteoclasts [39].
Conclusions
The results of the present study provide evidence that
osteocytic osteolysis is occurring in cortical lacunae dur-
ing mechanical unloading. Furthermore, our findings
suggest that Cx43 deficiency may protect against osteo-
cytic osteolysis during unloading in a manner similar to
the lower endocortical osteoclast activity our group [22]
and others [24] have documented previously in unloaded
Cx43 deficient mice. It may also be that unloading is not
able to further increase osteocytic osteolysis beyond the
level already elevated in Cx43 deficient mice at baseline.
Important limitations to the present study, including our
ability to resolve differences in lacunar size and identify
TRACP- osteocytes, would justify additional comprehen-
sive studies of this process. In particular, investigations
utilizing high-resolution nanocomputed tomography or
electron microscopy are warranted to more accurately
quantify lacunar morphology in response to Cx43 defi-
ciency and unloading. Cx43 may represent an important
target for the prevention of bone loss associated with
aging and disuse.
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